Dr. Paul Domanico is a life science executive and entrepreneur with forty years of experience. He is a multi-faceted, insightful leader. Paul has led international, multidisciplinary teams through drug and technology discovery, development, and introduction. He is a business and science mentor/advisor to global health consortia, universities, and medical schools.
VP, Technology Development, GSK: Commercialized technologies that opened new avenues for drug discovery and dramatically improved clinical success.
Founder, Innovalyst, LLC: Developed a robust methodology that helped clients optimize over a dozen product portfolios, commercialize twenty-six life science technologies, and establish new markets for four existing product lines.
Senior Director, Global Health Sciences, CHAI: Delivered a portfolio of new medicines, diagnostics, and technologies, provided clinical science and implementation research leadership, and ensured that healthcare is dramatically improved and sustained.
Global Health Research Fellow, CHAI; Catalyzes the development of capabilities that will transform global health. Co-leads CHAI’s SCD Program.